Get the Stockscreener App
3.56
2.47%
-0.09
After Hours:
3.58
0.02
+0.56%
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Forecast
The Scinai Immunotherapeutics Ltd Adr (SCNI) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.198, representing a -94.44% decrease from the current price of $3.56. The highest analyst price target is $0.234, and the lowest is $0.162.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SCNI Price Target
Average 0.3442
(-90.33% Downside)
Is Scinai Immunotherapeutics Ltd Adr (SCNI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 47.62 | Neutral |
| STOCH(9,6) | 39.13 | Neutral |
| STOCHRSI(14) | 32.32 | Neutral |
| MACD(12,26) | -0.0329 | Sell |
| ADX(14) | 25.13 | Buy |
| William %R | -72.23 | Neutral |
| CCI(14) | -15.98 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.571
Sell
|
3.5893
Sell
|
| MA20 |
3.642
Sell
|
3.6155
Sell
|
| MA50 |
3.6444
Sell
|
3.6767
Sell
|
| MA100 |
3.7574
Sell
|
3.8484
Sell
|
| MA200 |
4.1749
Sell
|
4.5488
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, SCNI could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on SCNI, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 47.62 indicates that SCNI is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 39.13 indicates that SCNI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 32.32 indicates that SCNI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.13 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -15.98 indicates that SCNI is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term SCNI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Scinai Immunotherapeutics Ltd Adr financial reports and earnings history, Scinai Immunotherapeutics Ltd Adr (SCNI) stock could reach $2.4284 by 2030, $10.70 by 2040 and $14.69 by 2050. See the projected annual prices until 2050 of the Scinai Immunotherapeutics Ltd Adr stock below:
- Scinai Immunotherapeutics Ltd Adr (SCNI) is expected to reach an average price of $5.8014 in 2035, with a high prediction of $6.30 and a low estimate of $5.8014. This indicates an $62.96% rise from the last recorded price of $3.56.
- Scinai Immunotherapeutics Ltd Adr (SCNI) stock is projected to chart a bullish course in 2040, with an average price target of $10.81, representing an $203.53% surge from its current level. The forecast ranges from a conservative $4.8114 to a sky-high $10.70.
- Our analysts predict Scinai Immunotherapeutics Ltd Adr (SCNI) to jump 142.19% by 2045, soaring from $8.6499 to an average price of $8.6218, potentially reaching $9.2127. While $8.6499 is the low estimate, the potential upside is significant.
- Scinai Immunotherapeutics Ltd Adr (SCNI) stock is expected to climb by 2050, reaching an average of $13.95, a $291.91% jump from its current level. However, a wide range of estimates exists, with high and low targets of $14.69 and $14.02, respectively, highlighting the market's uncertainty.
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Year by Year Forecast
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Price Forecast for 2024
Our forecast for SCNI stock price in 2024 now indicates an average price target of $0.4371 with a high forecast of $0.8296 and a low forecast of $0.0446. The average prediction reflects an decrease of -87.72% from the last recorded price of $3.56.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $0.1817 | $0.162 | $0.234 | -94.89% |
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Price Forecast for 2025
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) is expected to reach an average price of $0.4106 in 2025, with a high prediction of $0.7607 and a low estimate of $0.0605. This indicates an -88.47% fall from the last recorded price of $3.56.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.1988 | $0.1581 | $0.2394 | -94.42% |
| February, 2025 | $0.2701 | $0.1308 | $0.2892 | -92.41% |
| March, 2025 | $0.3138 | $0.3444 | $0.2738 | -91.18% |
| April, 2025 | $0.1784 | $0.3142 | $0.2681 | -94.99% |
| May, 2025 | $0.1532 | $0.1669 | $0.1321 | -95.70% |
| June, 2025 | $0.2252 | $0.2257 | $0.1952 | -93.68% |
| July, 2025 | $0.2185 | $0.2388 | $0.1946 | -93.86% |
| August, 2025 | $0.1135 | $0.162 | $0.1535 | -96.81% |
| September, 2025 | $0.1065 | $0.1116 | $0.0824 | -97.01% |
| October, 2025 | $0.0582 | $0.0605 | $0.0559 | -98.36% |
| November, 2025 | $0.7875 | $0.6712 | $0.6279 | -77.88% |
| December, 2025 | $0.7678 | $0.8178 | $0.7607 | -78.43% |
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Price Forecast for 2026
The predicted value for Scinai Immunotherapeutics Ltd Adr (SCNI) in 2026 is set at an average of $0.7791. Estimates vary from a peak of $1.2477 to a trough of $0.3105, indicating an -78.12% surge from the present price of $3.56.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.6271 | $0.7629 | $0.7321 | -82.38% |
| February, 2026 | $0.5713 | $0.6003 | $0.5732 | -83.95% |
| March, 2026 | $0.6128 | $0.6286 | $0.5828 | -82.79% |
| April, 2026 | $0.5678 | $0.5881 | $0.5718 | -84.05% |
| May, 2026 | $0.4323 | $0.4836 | $0.4952 | -87.86% |
| June, 2026 | $0.3948 | $0.4075 | $0.3935 | -88.91% |
| July, 2026 | $0.3197 | $0.3105 | $0.3289 | -91.02% |
| August, 2026 | $1.305 | $1.2116 | $1.1454 | -63.34% |
| September, 2026 | $1.2471 | $1.2971 | $1.2477 | -64.97% |
| October, 2026 | $1.0758 | $1.2116 | $1.1961 | -69.78% |
| November, 2026 | $0.9895 | $1.0337 | $1.0143 | -72.21% |
| December, 2026 | $0.9998 | $1.03 | $0.9709 | -71.92% |
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Scinai Immunotherapeutics Ltd Adr (SCNI) is $1.1476, with a high forecast of $1.7346 and a low forecast of $0.5606. This indicates an -67.76% decrease from the last price of $3.56.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.9172 | $0.9375 | $0.9392 | -74.24% |
| February, 2027 | $0.7512 | $0.8025 | $0.837 | -78.90% |
| March, 2027 | $0.6424 | $0.6724 | $0.7047 | -81.95% |
| April, 2027 | $0.5812 | $0.5606 | $0.6019 | -83.67% |
| May, 2027 | $1.8225 | $1.752 | $1.6656 | -48.81% |
| June, 2027 | $1.7264 | $1.7764 | $1.7346 | -51.51% |
| July, 2027 | $1.5246 | $1.6604 | $1.6601 | -57.18% |
| August, 2027 | $1.4076 | $1.4671 | $1.4553 | -60.46% |
| September, 2027 | $1.3797 | $1.4122 | $1.3661 | -61.24% |
| October, 2027 | $1.2666 | $1.2869 | $1.3115 | -64.42% |
| November, 2027 | $1.07 | $1.1213 | $1.1787 | -69.94% |
| December, 2027 | $0.9231 | $0.9531 | $1.0159 | -74.07% |
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Price Forecast for 2028
In 2028, Scinai Immunotherapeutics Ltd Adr (SCNI) is projected to reach an average price of $1.7698, with a high projection of $2.7289 and a low estimate of $0.8106. This indicates an -50.29% fall from the last price of $3.56.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.8428 | $0.8106 | $0.8749 | -76.33% |
| February, 2028 | $2.34 | $2.2866 | $2.1907 | -34.27% |
| March, 2028 | $2.2056 | $2.2556 | $2.2215 | -38.04% |
| April, 2028 | $1.9733 | $2.1091 | $2.1241 | -44.57% |
| May, 2028 | $1.8676 | $1.8979 | $1.8964 | -47.54% |
| June, 2028 | $1.7597 | $1.7922 | $1.7672 | -50.57% |
| July, 2028 | $1.616 | $1.6363 | $1.6838 | -54.61% |
| August, 2028 | $1.3696 | $1.3871 | $1.5204 | -61.53% |
| September, 2028 | $1.2037 | $1.2337 | $1.2962 | -66.19% |
| October, 2028 | $1.1043 | $1.0607 | $1.1478 | -68.98% |
| November, 2028 | $2.809 | $2.8193 | $2.7289 | -21.10% |
| December, 2028 | $2.6849 | $2.7349 | $2.7084 | -24.58% |
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Price Forecast for 2029
The 2029 price forecast for Scinai Immunotherapeutics Ltd Adr Stock (SCNI) is $2.2758 on average, with a high prediction of $3.2409 and a low estimate of $1.3107. This represents an -36.07% decrease from the previous price of $3.56.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.3849 | $2.3849 | $2.5914 | -33.01% |
| February, 2029 | $2.2781 | $2.316 | $2.284 | -36.01% |
| March, 2029 | $2.1396 | $2.1721 | $2.1701 | -39.90% |
| April, 2029 | $1.9654 | $1.9857 | $2.0561 | -44.79% |
| May, 2029 | $1.6807 | $1.6982 | $1.8622 | -52.79% |
| June, 2029 | $1.4843 | $1.5143 | $1.5997 | -58.31% |
| July, 2029 | $1.3658 | $1.3107 | $1.4208 | -61.64% |
| August, 2029 | $3.3188 | $3.3521 | $3.2409 | -6.78% |
| September, 2029 | $3.1642 | $3.2142 | $3.1953 | -11.12% |
| October, 2029 | $2.826 | $2.826 | $3.0631 | -20.62% |
| November, 2029 | $2.6886 | $2.7331 | $2.7174 | -24.48% |
| December, 2029 | $2.5195 | $2.552 | $2.5729 | -29.23% |
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Price Forecast for 2030
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) is expected to reach an average price of $2.6653 in 2030, with a high forecast of $3.7698 and a low forecast of $1.5608. This signifies an -25.13% decrease from the last price of $3.56.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.2439 | $2.2531 | $2.4284 | -36.97% |
| February, 2030 | $1.9919 | $2.0094 | $2.1528 | -44.05% |
| March, 2030 | $1.7649 | $1.7949 | $1.9033 | -50.42% |
| April, 2030 | $1.6273 | $1.5608 | $1.6938 | -54.29% |
| May, 2030 | $3.8286 | $3.8848 | $3.7698 | +7.55% |
| June, 2030 | $3.6435 | $3.6935 | $3.6822 | +2.34% |
| July, 2030 | $3.267 | $3.267 | $3.5347 | -8.23% |
| August, 2030 | $3.0992 | $3.1437 | $3.1509 | -12.95% |
| September, 2030 | $2.8995 | $2.932 | $2.9758 | -18.55% |
| October, 2030 | $2.5856 | $2.5948 | $2.8007 | -27.37% |
| November, 2030 | $2.3031 | $2.3206 | $2.4869 | -35.31% |
| December, 2030 | $2.0455 | $2.0755 | $2.2068 | -42.54% |
2.02%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):